Michael Nathan Cohen
Michael Nathan Cohen
Tufts Medical Center
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
E Kerem, S Hirawat, S Armoni, Y Yaakov, D Shoseyov, M Cohen, ...
The Lancet 372 (9640), 719-727, 2008
Dynamic filopodia transmit intermittent Delta-Notch signaling to drive pattern refinement during lateral inhibition
M Cohen, M Georgiou, NL Stevenson, M Miodownik, B Baum
Developmental cell 19 (1), 78-89, 2010
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
M Wilschanski, LL Miller, D Shoseyov, H Blau, J Rivlin, M Aviram, ...
European Respiratory Journal 38 (1), 59-69, 2011
Efficacy and safety of asenapine in a placebo-and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia
JM Kane, M Cohen, J Zhao, L Alphs, J Panagides
Journal of clinical psychopharmacology 30 (2), 106-115, 2010
A retrospective analysis of outcomes using three common methods for immediate breast reconstruction
SL Spear, MK Newman, MS Bedford, KA Schwartz, M Cohen, ...
Plastic and reconstructive surgery 122 (2), 340-347, 2008
Two-stage prosthetic breast reconstruction using AlloDerm including outcomes of different timings of radiotherapy
SL Spear, M Seruya, SS Rao, S Rottman, E Stolle, M Cohen, KM Rose, ...
Plastic and reconstructive surgery 130 (1), 1-9, 2012
Transducible peptide therapy for uveal melanoma and retinoblastoma
JW Harbour, L Worley, D Ma, M Cohen
Archives of Ophthalmology 120 (10), 1341-1346, 2002
Qualitative research
C Russell, M Gregory, D Ciliska, J Ploeg, G Guyatt, M Cohen, A Willman, ...
Mosby, 2005
Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture
CL Shields, S Kaliki, MN Cohen, PW Shields, M Furuta, JA Shields
Eye 29 (8), 1027-1035, 2015
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced …
V Diehl, M Loeffler, M Pfreundschuh, U Ruehl, D Hasenclever, ...
Annals of oncology 6 (9), 901-910, 1995
Mental health practices of Ontario family physicians: a study using qualitative methodology
MA Craven, M Cohen, D Campbell, J Williams, N Kates
The Canadian Journal of Psychiatry 42 (9), 943-949, 1997
Telomerase activity in patients with transitional cell carcinoma: a preliminary study
MA Rahat, N Lahat, H Gazawi, MB Resnick, Y Sova, G Ben‐Ari, M Cohen, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1999
The importance of structured noise in the generation of self-organizing tissue patterns through contact-mediated cell–cell signalling
M Cohen, B Baum, M Miodownik
Journal of the Royal Society Interface 8 (59), 787-798, 2011
Analysis of the nerve branches to the orbicularis oculi muscle of the lower eyelid in fresh cadavers
JB Lowe III, M Cohen, DA Hunter, SE Mackinnon
Plastic and reconstructive surgery 116 (6), 1743-1749, 2005
Molecular genetic characterization of tamoxifen-associated endometrial cancer
M Prasad, H Wang, W Douglas, RR Barakat, LH Ellenson
Gynecologic oncology 96 (1), 25-31, 2005
Detrusor resistive index evaluated by Doppler ultrasonography as a potential indicator of bladder outlet obstruction
A Belenky, Y Abarbanel, M Cohen, O Yossepowitch, PM Livne, ...
Urology 62 (4), 647-650, 2003
A subjective rating scale for evaluating the appearance outcome of autologous breast reconstruction
M Cohen, B Evanoff, LT George, KE Brandt
Plastic and Reconstructive Surgery 116 (2), 440-449, 2005
The role of the neuropeptide Y-2 receptor in liporemodeling: NPY mediated adipogenesis and adipose graft maintenance
SB Baker, M Cohen, L Kuo, M Johnson, A Al-Attar, Z Zukowska
Plastic and reconstructive surgery 123 (2), 486, 2009
Genetic and electrophysiological characteristics of recurrent acute pancreatitis
S Werlin, FM Konikoff, Z Halpern, O Barkay, B Yerushalmi, E Broide, ...
Journal of Pediatric Gastroenterology and Nutrition 60 (5), 675-679, 2015
Immunohistochemistry with anti-BRAF V600E (VE1) mouse monoclonal antibody is a sensitive method for detection of the BRAF V600E mutation in colon cancer: evaluation of 120 …
K Dvorak, A Higgins, J Palting, M Cohen, P Brunhoeber
Pathology & Oncology Research 25, 349-359, 2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20